NEW YORK (GenomeWeb) – Molecular diagnostics firm Genomed has developed a prophylactic whole-genome sequencing test for consumers that it is currently beta testing in the Polish market. The company, based in Warsaw, offers a variety of sequencing-based tests and genetic counseling services for inherited diseases, including BGI's NIFTY noninvasive prenatal screening test, as well as a number of research services.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.